Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C1883
http://purl.obolibrary.org/obo/NCIT_C1883
|
|---|---|
| Preferred Name | Vitamin D3 Analogue ILX23-7553 |
| Definitions |
A vitamin D3 analogue with potential antineoplastic activity. ILX23-7553 binds to and activates the vitamin D receptor, a cytoplasmic polypeptide expressed in normal vitamin D responsive tissues, but also overexpressed in certain cancers including hepatocellular carcinoma and pancreatic cancer. Mediated through vitamin D receptor, this agent induces cancer cell differentiation, inhibits cancer cell growth and induces apoptosis. In addition, ILX23-7553 may also induce growth arrest and apoptosis independent of vitamin D receptor activation through mechanisms that are not fully elucidated.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A vitamin D3 analogue with potential antineoplastic activity. ILX23-7553 binds to and activates the vitamin D receptor, a cytoplasmic polypeptide expressed in normal vitamin D responsive tissues, but also overexpressed in certain cancers including hepatocellular carcinoma and pancreatic cancer. Mediated through vitamin D receptor, this agent induces cancer cell differentiation, inhibits cancer cell growth and induces apoptosis. In addition, ILX23-7553 may also induce growth arrest and apoptosis independent of vitamin D receptor activation through mechanisms that are not fully elucidated. |
|---|---|
| prefLabel | Vitamin D3 Analogue ILX23-7553
|
| label | Vitamin D3 Analogue ILX23-7553
|
| PDQ_Closed_Trial_Search_ID | 37861
|
| code | C1883
|
| prefixIRI | NCIT:C1883
|
| in_subset | |
| Preferred_Name | Vitamin D3 Analogue ILX23-7553
|
| FDA_UNII_Code | O13QTC8612
|
| Contributing_Source | FDA
|
| Maps_To | Vitamin D3 Analogue ILX23-7553
|
| CAS_Registry | 118694-43-2
|
| NCI_Drug_Dictionary_ID | 37861
|
| Legacy Concept Name | ILX23-7553
|
| type | |
| ALT_DEFINITION | A substance that is being studied as an anticancer drug.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 37861
|
| Semantic_Type | Pharmacologic Substance
|
| UMLS_CUI | C0966846
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |